Water at DNA surfaces: Ultrafast dynamics in minor groove recognition by Pal, Samir Kumar et al.
Water at DNA surfaces: Ultrafast dynamics in minor
groove recognition
Samir Kumar Pal, Liang Zhao, and Ahmed H. Zewail*
Laboratory for Molecular Sciences, Arthur Amos Noyes Laboratory of Chemical Physics, California Institute of Technology, Pasadena, CA 91125
Contributed by Ahmed H. Zewail, May 21, 2003
Water molecules at the surface of DNA are critical to its equilibrium
structure, DNA–protein function, and DNA–ligand recognition.
Here we report direct probing of the dynamics of hydration, with
femtosecond resolution, at the surface of a DNA dodecamer duplex
whose native structure remains unperturbed on recognition in
minor groove binding with the bisbenzimide drug (Hoechst 33258).
By following the temporal evolution of fluorescence, we observed
two well separated hydration times, 1.4 and 19 ps, whereas in bulk
water the same drug is hydrated with time constants of 0.2 and 1.2
ps. For comparison, we also studied calf thymus DNA for which the
hydration exhibits similar time scales to that of dodecamer DNA.
However, the time-resolved polarization anisotropy is very differ-
ent for the two types of DNA and clearly elucidates the rigidity in
drug binding and difference in DNA rotational motions. These
results demonstrate that hydration at the surface of the groove is
a dynamical process with two general types of trajectories; the
slowest of them (20 ps) are those describing dynamically ordered
water. Because of their ultrafast time scale, the ‘‘ordered’’ water
molecules are the most weakly bound and are accordingly involved
in the entropic (hydrationdehydration) process of recognition.
Hydration of DNA plays important role in its structure,conformation, and function. Of significance to the function
is the selective recognition by DNA of small molecules (ref. 1 and
references therein). X-ray crystallography, NMR, dielectric re-
laxation, and molecular dynamics simulation studies have shown
that a significant amount of water molecules are bound to DNA
(for reviews, see refs. 2–6). For example, measurements of
dielectric relaxation caused by water molecules bound to DNA
in mixed water-ethanol solutions have found that 18–19 water
molecules per nucleotide are present in B-DNA, but only 13–14
water molecules are bound in A-DNA (5). The study also
suggested that a structural transition of poly(dG-dC)poly(dG-
dC) DNA from its B to Z form takes place on the removal of the
bound water molecules, preferentially from the phosphate
groups.
The molecular picture of hydration in the minor groove of
B-DNA is unique. An x-ray crystallographic investigation (7)
followed by solution NMR study (8) on a model dodecamer
B-DNA duplex (for the sequence of AT tracts, CGCGAAT-
TCGCG) showed that the minor groove is hydrated in an
extensive and regular manner, with a zigzag ‘‘spine’’ of first-
and second-shell hydration along the f loor of the groove. In
contrast, hydration within the major groove is principally
confined to a monolayer of water molecules. The conforma-
tional energy calculation suggested that the presence of the
spine of hydration is the prime reason for the further narrow-
ing of minor groove (9).
The influence of drug binding on DNA hydration is striking.
Acoustic and densimetric studies have shown that a fraction (not
total) of the water molecules is released on recognition (10, 11).
Hence, the balance between enthalpic and entropic changes in
determining the overall free energy of recognition. The degree
of order in water dynamics is determined by the time scale of the
motion and is critical to the hydrophobic contribution. Recently,
studies of solvation dynamics have been reported for an extrinsic
chromogenic probe, inserted into DNA either by covalent
adduction of coumarin dye (12) or hydrophobic intercalation of
acridine dye (13). The fluorescence results (12) give two relax-
ation time constants of 300 ps (47%) and 13 ns (53%), both
measured with 100-ps time resolution and attributed to the local
reorganization (by DNA andor water) in the modified DNA.
The results from femtosecond-resolved transient absorption (13)
suggest an ultrafast (within 200 fs) ‘‘repolarization’’ of nuclear
degrees of freedom of the DNA pocket. However, the lack of
information on structures for both complexes keeps unknown
the extent of perturbation on DNA. Moreover, neither study
gave the hydration dynamics in the DNA grooves. Using the
natural DNA bases to probe hydration is hampered by their
ultrafast lifetimes (ref. 14 and references therein).
In this article, we present our study of DNA hydration
dynamics, with femtosecond resolution, in the minor groove
(Fig. 1), using the dodecamer B-DNA duplex d(CGCAAATT-
TGCG) whose x-ray structure without and with the drug
Hoechst 33258 (H33258) has been reported (15, 16); the site for
recognition is the minor groove and remains unchanged on
binding. We follow the time evolution of the Stokes shift of the
fluorescence of the drug, bound to DNA, and obtain the decay
of the hydration correlation function. The function reflects the
rotational and translational motions of water molecules in the
minor groove. The drug, which is in a class of antimicrobial
agents (17), has high affinity to DNA (Kd  108 M); its
f luorescence intensity increases when complexed to DNA, rel-
ative to that in aqueous solution, and is accompanied by a
significant blue shift (18–20). We also report our study of calf
thymus DNA (CT-DNA) on binding to the same drug (H33258)
to compare with the dodecamer DNA. Finally, to probe the
rigidity of the drug and the time scale of its motion with DNA
we examined the time-resolved polarization anisotropy, r(t).
Experimental Procedures
Time-Resolved Studies. All of the transients were obtained by
using the femtosecond-resolved fluorescence up-conversion
technique. The detailed experimental setup is described else-
where (21). For the studies reported here, a fs excitation pulse
(200 nJ) was used at 350 nm. To measure time-resolved anisot-
ropy, r(t), and to construct hydration correlation function, C(t),
we followed the procedure detailed in our previous publications
(21–23).
Sample Preparation. CT-DNA (Sigma) and Hoechst 33258 (Mo-
lecular Probes, 99% pure) were used without further purifica-
tion. The drug was in the form of trihydrochloride, pentahydrate,
and at neutral pH it only has one positive charge (see below,
Scheme 1). The dodecamer DNA with sequence CGCAAATT-
TGCG was synthesized, purified by reverse-phase cartridge,
annealed to make duplex, and supplied by Gene Link (Haw-
thorne, NY). The purity of the duplex was checked by urea
PAGE; essentially one band was characterized by the supplier.
Aqueous DNA solutions were prepared in a Tris buffer (0.01 M
Abbreviations: CT-DNA, calf thymus DNA; TRES, time-resolved emission spectra.
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Tris0.001 M EDTA) at pH 7.4 in water from a Nanopure
(Dubuque, IA) purification system.
The DNA–drug complexes were prepared by mixing the drug
H33258 (96 M) with the duplex (144 M) in the aqueous buffer
solutions with continuous stirring for 4 h. The yield of the
complexes is 99% (1:1 complex) at our drug concentration,
because the equilibrium constant is 108 M1 (24). The proce-
dure for making CT-DNA aqueous solution is similar to that of
ref. 20. Solid CT-DNA (1 mgml) was dissolved into buffer
solutions. The DNA solutions were sonicated for 30 s to reduce
the DNA chain length and stirred for 1 h. The ratio of absorption
at 260 and 280 nm for the DNA solutions gave a value 1.84, in
accord with the limit of 1.8–1.9 for highly purified preparation
of DNA (25).
For the dodecamer duplexes, the complexes are 1:1, given the
equilibrium constant and the relative concentrations. For CT-
DNA, the drug sites are far apart because of the concentration
used. The nucleotide concentration was determined by absorp-
tion spectroscopy of CT-DNA using the average extinction
coefficient per nucleotide of CT-DNA (6,600 M1cm1 at 260
nm) (20) and found to be 2.5 mM, i.e., 1.25 mM for base pairs.
A known concentrated drug solution was added dropwise to the
CT-DNA solutions with continuous stirring for 2 h to achieve a
final concentration of 50 M for the drug. Accordingly, we
estimate that 25 bp of CT-DNA are available for each drug
molecule.
Results
Drug in Bulk Water. The steady-state fluorescence spectra of the
drug in three neat solvents are presented in Fig. 2 Upper. The
spectra show a large red solvatochromic effect. The fluorescence
maximum changes from 436 nm in dioxane to 477 nm in ethanol
and to 510 nm in aqueous buffer solutions. The effect of DNA
binding on the fluorescence intensity and maxima is shown in
Fig. 2 Lower.
In water, the fluorescence is quenched dramatically; the
quantum yield is 0.015 in water and increases to 0.5 in ethanol
(19). It is known (20, 26) that two major processes are involved
in the deactivation of the excited state. At high pH (7.0) the
excited molecule undergoes intramolecular proton transfer from
the phenol (see below) to the closest benzimidazole nitrogen,
resulting in a keto structure. In polar solvents, the fluorescence
intensity decreases and is dominated by emission from the keto
form. The deactivation at low pH values (7.0), and on the
complexation with DNA, mainly involves rotation along the
bisbenzimide axis (20), similar to other cases involving charge
transfer (27). The solvent’s pH, polarity, and rigidity determine
the wavelength and yield of emission. We have studied the
lifetime of the drug in bulk water and found it to be multiple
Fig. 1. The x-ray structure of the drug Hoechst 33258 with the dodecamer
duplex DNA. The structure was downloaded from the Protein Data Bank (ID
code 264D) and handled with the program WEBLAB VIEWERLITE (see ref. 16). In the
absence of the drug there are 71 water molecules with the dodecamer (15),
and in the presence of the drug only 18 water molecules (green balls) are
present. The location with respect to the groove is more clear in Fig. 6.
Scheme 1. Molecular structures of the drug (Hoechst 33258) and its inter-
action with the dodecamer DNA. Four moieties are indicated in the drug
structure: a piperazine (nonaromatic) ring (Pip), two benzimidazole (aromat-
ic) rings (Bz1 and Bz2), and a phenyl (aromatic) ring (Ph). Possible free
rotations about the connecting bonds are indicated with arrows. Two three-
centered hydrogen bonds between the drug (two NOH bonds of N1 and N3)
and DNA bases are shown in accord with crystal structure (16). At neutral pH
the drug molecule (trihydrochloride form) has only one positive charge on the
terminal nitrogen atom of the Pip ring (44). In the view presented, the drug is
projected out from the minor groove (see Fig. 1); the atom colors for the drug
are red for oxygen, white for hydrogen, blue for nitrogen, and gray for
carbon.
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exponentials (ps and ns ranges) and to depend on its concen-
tration. The enhancement of the ps component, characteristic of
high pH decay (20) at high concentration, may suggest the
presence of ground-state conformations whose equilibrium
changes with concentrations andor aggregation; a subset of
those conformations is more poised for twistingproton transfer.
In contrast, in DNA the fluorescence decay is dominated by ns
components and does not change with concentration of DNA
studied (M to mM); DNAdrug remains at 1.5.
Femtosecond-resolved fluorescence up-conversion transients
of the drug in bulk water (buffer) are presented in Fig. 3 Upper
Left for three characteristic wavelengths; we have studied at least
13 of these transients at different wavelengths. The fs transients
are typical of those observed for other chromophores in water
(22, 23). On the blue edge of the spectrum, the signal is seen to
decay (1.5 ps), whereas on the red edge it rises on a similar time
scale. The signal decays with time constants of 40 and 500 ps
in the time window studied, up to 200 ps. From the transients it
is clear that the contribution of ultrafast hydration is well
separated from the nonradiative processes. Note that hydration
is essentially independent of details of the solute fluorophore
(see, e.g., refs. 21–23 and references therein).
From this family of transients we constructed the time-
resolved emission spectra (TRES) shown in Fig. 3 Upper Right
and the hydration correlation function C(t) given in Fig. 3 Lower.
C(t) shows an apparent biexponential decay with time constants
of 195 fs (33%) and 1.2 ps (67%). This behavior is typical of
hydration of a molecular probe in bulk water (22, 28, 29). The
overall spectral shift we observed is 3,184 cm1; any sub-100-fs
component in the dynamics would be unresolved. To complete
the picture regarding bulk dynamics of the drug in water and in
a less polar solvent (for comparison with DNA environment), we
made similar studies of the drug in ethanol (data not shown). In
this case, decays are slower than those in water and consistently
show the time scale of solvation for ethanol [the average
solvation time is 16 ps (30)].
To elucidate the time scale for the rotational diffusion of the
drug and its complex we measured the time-resolved anisotropy,
r(t), using single-photon counting techniques (Fig. 3 Lower
Inset). At t  0, r(t) 0.4 and decays to the base line (properly
corrected for polarizationintensities) with   530 ps. Accord-
ing to the Stokes–Einstein–Debye hydrodynamics theory, and
assuming a prolate shape for the drug molecule (31, 32), the
rotational times in water range from 1 to 5 ns, considering the
boundary conditions. Our measured value of 530 ps must include
Fig. 2. (Upper) Normalized steady-state fluorescence spectra of the drug
H33258 in three solvents: dioxane, ethanol, and water. For water, both
absorption and emission are shown. The excitation wavelength (350 nm) is
indicated by an arrow. (Lower) Fluorescence spectra of DNA–drug complexes
in aqueous solutions. For comparison we also include the fluorescence spec-
trum of the drug H33258 in water (buffer) solution. The three spectra corre-
spond to solutions with the same total concentration of the drug.
Fig. 3. (Upper Left) Femtosecond-resolved fluorescence at three character-
istics wavelengths for H33258 in water (buffer). The excitation wavelength
was 350 nm. (Upper Right) The corresponding normalized TRES. In water,
the shift from the initial t 0 spectrum to 5-ps spectrum completes the process
of hydration. The spectrum at equilibrium (steady-state) is shown for com-
parison. (Lower) Hydration correlation function, C(t), of the drug H33258
in water. (Lower Inset) The time-resolved anisotropy, r(t), of the probe drug
in water (buffer) at emission wavelength 510 nm with excitation at 400 nm
using single-photon counting. Note the difference in time scales between C(t)
and r(t).












the twisting process, which changes the anisotropy. Note that the
r(t) decay in water is on a much longer time scale than that of
hydration. Thus rotational diffusion and conformational changes
are separable in their time scales from that of hydration.
Vibrational relaxation is insignificant given the calculated 0O0
transition in water (316.5 nm) and for the reasons given in ref. 23.
Drug–DNA Dodecamer Complex. Fig. 4 Upper Left shows three
characteristic transients obtained from up-conversion experi-
ments on the drug–DNA dodecamer complex in aqueous buffer
solutions; other wavelengths are not shown. On the blue edge of
the spectrum the signals decay on different time scales depend-
ing on wavelengths, whereas on the red edge the signal is seen
to rise. The constructed TRES are shown in Fig. 4 Upper Right,
indicating that hydration is complete within 100 ps; the spectrum
at 100 ps reaches the equilibrium spectrum obtained from
steady-state fluorescence.
The C(t) function, as shown in Fig. 4 Lower, is a sum of two
exponentials with the time constants of 1.4 ps (64%) and 19 ps
(36%); any sub-100-fs components in these dynamics are unre-
solved. The net spectral shift observed is 1,304 cm1, consistent
with the behavior depicted in Fig. 2. To ascertain the degree of
orientational rigidity of the drug in the complex we obtained the
fluorescence anisotropy, r(t), decay at 510 nm by using single-
photon counting. The r(t) is observed (Fig. 4 Lower Inset) to
decay with a time constant of 5.5 ns (the estimated hydrody-
namic rotational relaxation times of the complex are in the range
10–50 ns). The one order of magnitude lengthening of the drug
anisotropy decay in dodecamer, compared with that in the bulk,
is consistent with a rigid drug binding in the minor groove.
Drug–CT-DNA Complex. In Fig. 5 Upper Left, we show the up-
conversion signals at three characteristic wavelengths; other
wavelengths are not shown. The time scales of the decay in the
blue edge and corresponding rise in the red edge are similar to
those observed in the dodecamer duplex. The constructed TRES
in Fig. 5 Upper Right indicate that at 100 ps the equilibrium of the
fluorescence, as observed from steady-state emission spectrum,
has been reached.
The C(t) function for the CT-DNA in Fig. 5 Lower can be fitted
to a biexponential decay with time constants of 1.1 ps (60%) and
19 ps (40%); any sub-100-fs components in these dynamics are
unresolved. The net spectral shift observed is 1,582 cm1. The
time constants along with their contributions are similar to those
observed in the dodecamer duplex. But, the fluorescence an-
isotropy at 510 nm decays with a different time constant:55 ns
(major component), compared with that of5.5 ns in the duplex.
This finding is consistent with the fact that natural CT-DNA is
much longer than the duplex DNA (12 pairs of bases only), but
the effect of binding to sites of genomic DNA is another factor
to consider.
Discussion
Summarizing our observations we can make the following points:
(i) Hydration dynamics in the minor grooves of both types of
Fig. 4. (Upper Left) Femtosecond-resolved fluorescence at three character-
istics wavelengths for the drug–dodecamer DNA complex. The excitation
wavelength was 350 nm. (Upper Right) The corresponding normalized TRES.
The dotted line shows the steady-state emission spectrum of the complex.
(Lower) Hydration correlation function, C(t), of the complex. (Lower Inset) The
time-resolved anisotropy, r(t), of the probe drug in the complex at emission
wavelength 510 nm, with excitation at 400 nm using single-photon counting.
Note the difference in time scales between C(t) and r(t).
Fig. 5. (Upper Left) Femtosecond-resolved fluorescence at three character-
istics wavelengths for the drug–CT-DNA complex. The excitation wavelength
was 350 nm. (Upper Right) The corresponding normalized TRES. The dotted
line shows the steady-state emission spectrum of the complex. (Lower) Hy-
dration correlation function, C(t), of the complex. (Lower Inset) The time-
resolved anisotropy, r(t), of the probe drug in the complex at emission wave-
length 510 nm, with excitation at 400 nm using single-photon counting. Note
the difference in time scales between C(t) and r(t).
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DNA (dodecamer duplex and calf thymus) are similar but differ
substantially from those in bulk water; (ii) for both types of
DNA, and within our time resolution, a ‘‘bimodal’’ hydration
behavior with two distinct time constants,1 ps (60%) and20
ps (40%), was observed, reflecting the presence of two types of
water, bulk-type, labile water and weakly bound, ordered water;
and (iii) rotational diffusion of the drug–DNA complexes is
much slower than that of the drug in bulk water (530 ps), but is
different for the two types of DNA studied; 5.5 ns for dodecamer
duplex and 55 ns for calf thymus. These results indicate the
rigidity caused by binding in the minor grooves and the disparity
in time scales of hydration and rotational diffusion.
The observed bimodality (Fig. 6) in surface hydration of
DNA(s) are in fact consistent with our previous reports (21–23)
on hydration dynamics at protein surfaces. The DNA hydration
time of 19 ps (40%) for the weakly bound water is in line with
those observed for the protein surface hydration: Subtilisin
Carlsberg (38 ps, 39%), Monellin (16 ps, 54%), and -chymo-
trypsin (28 ps, 10%). Relating these times of the correlation
functions to residence times in the water layer identifies the
effect of first-shell polarization caused by the restricted motions
of water molecules by rotational and translational diffusion (33).
These residence times are for a layer of nm thickness (22) and
for the weakest-bound water because our measurements span
the earliest possible (fs) time scale. The persistence of time scales
in DNA and proteins is consistent with solvation by water (not
internal groups), as discussed elsewhere (23).
Considering the equilibrium between water molecules and the
DNA sites, a residence time of minor grooves with koff 5 1010
s1 and diffusion controlled kon  1010 M1s1 (34) gives Kd
 5 M, so that each accessible site on the average would be in
contact with water for 90% of the time; the site has very high
occupancy at equilibrium. Dynamically speaking, however, the
site is in exchange with bulk, destroying the order on the ps time
scale, and this is the origin of bimodality (22, 33).
The residence time for ordered water relative to other time
constants of DNA is of significance to the stability and recog-
nition. First, we must consider the time scale of making and
breaking bonds of the dynamically ordered water, DOW, relative
to that of structural conformational changes, CC, by bending and
twisting (ref. 35 and references therein). The value of CC is
important to, for example, the change of the B form of DNA to
A and Z forms whose relative stabilities depend on the water
content and sequence; B form predominates in aqueous solution.
If DOW is shorter than CC then recognition is an effective
process with structural integrity. The loss of order on the ps time
scale is significant in increasing the entropy and it is possible that
this contribution to the free energy is governed by the change in
the rotations of water molecules. It is interesting that for this
drug and DNA sequence, the entropic contribution is indeed
dominant (36). Repeating these experiments for different drugs
or sequences should correlate the thermodynamics (37–39) with
the dynamics.
Second, it is important to compare the residence time of
weakly bound water, DOW, with the time of breakingmaking
hydrogen bonds, HB, in bulk water. With a few kcalmol barrier,
kinetically HB is on the order of a few picoseconds, and for an
effective recognition, DOW should not be orders of magnitude
longer than the value of HB, so that the efficiency becomes
optimum. If DOWHB  1, then the degree of order is that of
the bulk. Lastly, the time scale for the motion of the drug in the
groove, by orientational diffusion, OD, relative to that of DOW.
For the drug studied here, OD is much longer than DOW for both
types of DNA, as evidenced by the anisotropy, ensuring a well
defined geometry, certainly on the time scale of dynamically
ordered water.
The robustness of the range of values for the hydration times
in DNA (and proteins) is indicative of the nature of the layer,
being ordered on the molecular scale even in the presence of the
drug. This picture is consistent with the results of NMR study
(34) on the hydration and solution structure of the duplex
sequence we have used and its complex with a minor groove
binding drug, propamidine. It was found that complexation with
the drug has little effect on the residence times for water
molecules bound either in the major groove or at the sites in the
minor groove. The range of residence times was found to be
0.2–0.4 ns for surface water at grooves; the residence times of
water molecules in the major groove are an order of magnitude
shorter than for the most long-lived waters in the minor groove.
From the above discussion two points should be emphasized.
Our above-mentioned results of hydration dynamics in the two
DNA systems studied were obtained by using the time window
from zero and up to 200 ps. Longer-time Stokes shifts may be
present, reflecting the influence of more rigid water structure on
the time scale indicated by NMR studies (4, 40). However, the
resemblance of the evolving spectra to the maximum of steady-
state fluorescence spectrum in 100 ps [max()] indicates that
most of the dynamics are complete within our time window, but
a fraction of strongly bound water may still be present with a time
scale of sub-ns or longer [we measured the lifetime of the drug
in the dodecamer and found it to be 1.5 and 4 ns, consistent
with the values in the literature (20)]. We note that the ns decays
are similar for all DNA concentrations studied, which indicates
that the dodecamer remains as a double strand, and not as a
hairpin that is possible for central AT and terminal GC bases of
a single strand; NMR confirms the double-strand structure at 1.1
mM (34).
Because the ordered water is probed here around the drug in
the grooves, one must not ignore such water in the study of
recognition processes and drug design strategies (36). In fact,
studies using densimetric and ultrasonic measurements have
shown that a minor groove binding drug, netropsin, displaces,
depending on the base sequence, a significant number of water
molecules on complexation with a DNA duplex (10). We note
that thermodynamic measurements of release of water is con-
cerned with essentially all waters occupied in the grooves
whereas the dynamics experiments can detect only a small
subpopulation of a certain net of interfacial water molecules that
Fig. 6. Comparison of the hydration correlation functions for the drug–DNA
(dodecamer and calf thymus) complexes in aqueous buffer solutions. We also
include the result for the drug in bulk water (buffer) for comparison. (Inset)
The structured water (green balls) with the drug in the minor groove (see Fig.
1 and text), according to x-ray studies (16). The time scales given denote BW
(bulk water), DOW (dynamically ordered water), CC (conformational change
water), and SW (structural water); see text.












contribute to ligand binding. The dynamics of the ordered water
and its loss by, for example, rotational diffusion contribute to the
entropic process involved.
From a structural point of view, the drug studied here (Scheme
1) binds in the minor groove covering the sequence AATTT of
the central A tract, with the piperazine group close to one of the
GC region. It makes two three-centered hydrogen bonds from
the nitrogen atoms of benzimidazole rings to the N (A18) and O
(T7, T8, T19) atoms of the DNA bases. This hydrogen bonding
(and electrostaticdispersion interactions) is facilitated by the
presence of ordered water (entropic) around the drug; if ordered
water is involved in direct binding of the drug then enthalpic
contributions must be included. Hydrogen bonding is also pos-
sible for the drug (Scheme 1; nitrogens opposite to N1 and N3)
with water near the surface of the groove, which is more of a bulk
type in our bimodal distribution of hydration. The most weakly
bound water molecules are of critical importance to biological
function (41) and are unlikely to be seen in crystal structures or
by NMR (41). They are part of total hydration, which influences
structural and biological activities (42, 43). The residence times
of weakly bound water are only an order of magnitude different
from that of bulk, and they are the ones that have to be probed
with femtosecond resolution.
In conclusion, the study presented here characterizes, with
femtosecond resolution, the dynamics of hydrationdehydration
at the DNA surface of known local structure and with a drug in
the minor groove. The fact that the water is dynamically ordered
at the surface of DNA without spatial averaging or position
inhomogeneity of the drug (known structure) allow us to observe
the earliest processes of hydration dynamics. Recognition of
minor grooves by charge and shape complementarities, and
using directional hydrogen bonds, cannot be fully understood
from a static structure without including the role of water and the
time scale for the loss of the order. It may turn out that this
dynamically ordered water is also crucial for interfacial recog-
nition, not only of drugs but also between macromolecules.
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